The emerging role of electronic medical records in pharmacogenomics.
Clin Pharmacol Ther. 2011.
PMID: 21248726
Free PMC article.
Review.
Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 0 |
Search Results
6
results
Results by year
Citations
1 article found by citation matchingSearch results
Filters applied: . Clear all
Page 1
Did you mean
the emerging role of electronic medical record in pharmacogenomics.
(9 results)?
The emerging role of electronic medical records in pharmacogenomics.
Clin Pharmacol Ther. 2011 Mar;89(3):379-86. doi: 10.1038/clpt.2010.260. Epub 2011 Jan 19.
Clin Pharmacol Ther. 2011.
PMID: 21248726
Free PMC article.
Review.
Health-care information technology and genotyping technology are both advancing rapidly, creating new opportunities for medical and scientific discovery. ...By linking biological material to comprehensive medical records, large multi-institutional biob …
Health-care information technology and genotyping technology are both advancing rapidly, creating new opportunities for medical …
Leveraging electronic health records to assess the role of ADRB2 single nucleotide polymorphisms in predicting exacerbation frequency in asthma patients.
Pharmacogenet Genomics. 2018 Nov;28(11):256-259. doi: 10.1097/FPC.0000000000000355.
Pharmacogenet Genomics. 2018.
PMID: 30334910
Free PMC article.
These correspond to nonsynonymous single nucleotide polymorphisms at positions 16 [arginine to glycine (Arg16Gly); rs1042713] and 27 [glutamic acid to glutamine (Glu27Gln); rs1042714], which are relatively common (minor allele frequencies 40-50%), and have been well characterized …
These correspond to nonsynonymous single nucleotide polymorphisms at positions 16 [arginine to glycine (Arg16Gly); rs1042713] and 27 [glutam …
Role of Pharmacovigilance in India: An overview.
Online J Public Health Inform. 2015 Jul 1;7(2):e223. doi: 10.5210/ojphi.v7i2.5595. eCollection 2015.
Online J Public Health Inform. 2015.
PMID: 26392851
Free PMC article.
PV is concerns with the detection, assessment, understanding and prevention of ADRs. Pharmacogenetics and pharmacogenomics are an indispensable part of the clinical research. ...The research focus is shifting toward the use of data generated from platforms outside t …
PV is concerns with the detection, assessment, understanding and prevention of ADRs. Pharmacogenetics and pharmacogenomics are …
An assessment of patient perspectives on pharmacogenomics educational materials.
Pharmacogenomics. 2020 Apr;21(5):347-358. doi: 10.2217/pgs-2019-0175. Epub 2020 Apr 15.
Pharmacogenomics. 2020.
PMID: 32292118
Free PMC article.
Aim: Pharmacogenomics (PGx) holds potential to improve patient treatment; yet, effective patient educational materials are limited. ...
Aim: Pharmacogenomics (PGx) holds potential to improve patient treatment; yet, effective patient educational materials are limited. . …
Drug-resistant epilepsy classified by a phenotyping algorithm associates with NTRK2.
Acta Neurol Scand. 2019 Sep;140(3):169-176. doi: 10.1111/ane.13115. Epub 2019 Jun 20.
Acta Neurol Scand. 2019.
PMID: 31070779
OBJECTIVE: Up to 40% of patients with epilepsy become drug resistant (DRE). Genetic factors are likely to play a role. While efforts have focused on the transporter and target hypotheses, neither of them fully explains the pan-pharmacoresistance seen in DRE. MATERIALS AND …
OBJECTIVE: Up to 40% of patients with epilepsy become drug resistant (DRE). Genetic factors are likely to play a role. While efforts …
Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology.
Front Pharmacol. 2020 Aug 5;11:1184. doi: 10.3389/fphar.2020.01184. eCollection 2020.
Front Pharmacol. 2020.
PMID: 32848787
Free PMC article.
Review.
An explanation for the diversity in response to chemotherapy is genetic variation, leading to differences in expression and activity of metabolizing and transport enzymes as well as drug targets. Pharmacogenetic testing has emerged as a promising tool to predict and limit …
An explanation for the diversity in response to chemotherapy is genetic variation, leading to differences in expression and activity of meta …
Cite